Should we stop methotrexate or not for vaccination?
作者信息
Durez Patrick, Combe Bernard
机构信息
Rheumatology, Cliniques Universitaires Saint-Luc - Université catholique de Louvain (UCLouvain), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium
Rheumatology, CHU Montpellier, Montpellier, France.
出版信息
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002798.
Abstract
摘要
相似文献
1
Should we stop methotrexate or not for vaccination?接种疫苗时我们是否应该停用甲氨蝶呤？
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002798.
2
Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?银屑病关节炎、甲氨蝶呤与肝脏——风湿病学家是否将患者置于风险之中？
Rheumatology (Oxford). 2008 Jul;47(7):939-41. doi: 10.1093/rheumatology/ken158. Epub 2008 May 12.
3
Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.类风湿关节炎中甲氨蝶呤的治疗建议。
Ir Med J. 2009 Jun;102(6):170-2.
4
[Post-vaccination varicella in a patient receiving methotrexate].[接受甲氨蝶呤治疗的患者接种疫苗后发生水痘]
Rev Esp Quimioter. 2017 Jun;30(3):236-238. Epub 2017 Apr 5.
5
Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.用于风湿性和自身免疫性疾病的药物治疗
Med Clin North Am. 2016 Jul;100(4):719-31. doi: 10.1016/j.mcna.2016.03.001.
6
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.艾拉莫德引发甲氨蝶呤相关淋巴增殖性疾病的复发。
Ann Hematol. 2021 Nov;100(11):2849-2850. doi: 10.1007/s00277-021-04645-2. Epub 2021 Aug 22.
7
Cutaneous ulceration with methotrexate.甲氨蝶呤所致皮肤溃疡
Prescrire Int. 2003 Apr;12(64):59-60.
8
9
Cyclosporine and methotrexate for severe rheumatoid arthritis.
N Engl J Med. 1995 Dec 7;333(23):1568; author reply 1568-9.
10
Methotrexate-Associated Lymphoproliferative Disorder of the Stomach Observed by Magnifying Narrow-Band Imaging Endoscopy.
J Gastrointestin Liver Dis. 2019 Jun 1;28:145. doi: 10.15403/jgld-170.
引用本文的文献
1
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients.风湿免疫病患者接种第 4 剂 SARS-CoV-2 异源和同源加强疫苗。
Front Immunol. 2024 Jul 26;15:1427501. doi: 10.3389/fimmu.2024.1427501. eCollection 2024.
本文引用的文献
1
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.疫苗类型和免疫抑制治疗，但不是诊断，对风湿性疾病患者 COVID-19 疫苗接种后的抗体反应有重要影响。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002650.
2
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.免疫抑制治疗的免疫介导性炎症性疾病患者三剂 SARS-CoV-2 疫苗接种策略的免疫原性和安全性。
RMD Open. 2022 Nov;8(2). doi: 10.1136/rmdopen-2022-002417.
3
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials.在印度类风湿性关节炎或银屑病关节炎患者中接种ChAdOx1 nCov19疫苗后停用甲氨蝶呤（MIVAC I和II）：两项平行、评估者设盲、随机对照试验的结果
Lancet Rheumatol. 2022 Nov;4(11):e755-e764. doi: 10.1016/S2665-9913(22)00228-4. Epub 2022 Sep 12.
4
Physician Perspectives on Vaccination in Patients With Autoimmune Inflammatory Rheumatic Diseases: An International Survey.自身免疫性炎性风湿疾病患者疫苗接种的医生观点：一项国际调查
J Rheumatol. 2023 Feb;50(2):246-251. doi: 10.3899/jrheum.220135. Epub 2022 Nov 1.
5
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.接种疫苗后抗 SARS-CoV-2 中和抗体滴度可预测 RA 患者 24 周内的抗 S IgG 水平。
RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002575.
6
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.暂停使用甲氨蝶呤可预防 COVID-19 加强针接种后对奥密克戎 BA.1 和 BA.2 的中和作用受损。
RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002639.
7
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis.老年类风湿关节炎患者同时接受甲氨蝶呤治疗会降低对 SARS-CoV-2 mRNA 疫苗的第三剂（加强针）体液免疫反应。
RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002632.
8
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.接种 SARS-CoV-2 疫苗后风湿性疾病的 flares：综述。
Front Immunol. 2022 Jul 4;13:919979. doi: 10.3389/fimmu.2022.919979. eCollection 2022.
9
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.自身免疫性系统性疾病患者对 COVID-19 疫苗加强针的无应答或应答不佳。
J Autoimmun. 2022 Jul;131:102866. doi: 10.1016/j.jaut.2022.102866. Epub 2022 Jul 11.
10
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.在有炎症性疾病的成年人中，中断 2 周甲氨蝶呤治疗与持续治疗对 COVID-19 加强疫苗免疫的影响（VROOM 研究）：一项随机、开放标签、优效性试验。
Lancet Respir Med. 2022 Sep;10(9):840-850. doi: 10.1016/S2213-2600(22)00186-2. Epub 2022 Jun 27.
Zotero 插件